Media

Strongbridge Biopharma plc Provides Corporate Update and Reports Third Quarter 2017 Financial Results

Bonesupport – Cerament® G’s potential to prevent and manage biofilm-related bone infections highlighted in new high-profile publication

Nexstim gains FDA clearance to commercialise its NBT® system in the US for the treatment of depression

Nordic Nanovector to Present at Jefferies Global Healthcare Conference

Wilson Therapeutics’ Nomination Committee appointed

Altimmune Announces Third Quarter 2017 Financial Results and Provides Corporate Update

CERENIS Therapeutics acquires LYPRO Biosciences expanding its HDL strategy into immuno-oncology and chemotherapeutic drug delivery

Nordic Nanovector: Protocol Amendment filed in the UK to enable initiation of Phase 2 PARADIGME